sotalol has been researched along with Metabolic Syndrome in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cicletanine treatment significantly decreased the incidence of ventricular arrhythmias, increased cardiac cGMP and nitric oxide content and reduced cardiac cAMP level." | 7.78 | Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome. ( Drimba, L; Hegedüs, C; Németh, J; Peitl, B; Sári, R; Szilvássy, Z; Yin, D, 2012) |
| "Cicletanine treatment significantly decreased the incidence of ventricular arrhythmias, increased cardiac cGMP and nitric oxide content and reduced cardiac cAMP level." | 3.78 | Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome. ( Drimba, L; Hegedüs, C; Németh, J; Peitl, B; Sári, R; Szilvássy, Z; Yin, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drimba, L | 1 |
| Hegedüs, C | 1 |
| Yin, D | 1 |
| Sári, R | 1 |
| Németh, J | 1 |
| Szilvássy, Z | 1 |
| Peitl, B | 1 |
1 other study available for sotalol and Metabolic Syndrome
| Article | Year |
|---|---|
Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pa | 2012 |